Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Short Interest Update

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) was the target of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 22,694 shares, an increase of 95.0% from the May 31st total of 11,635 shares. Based on an average daily volume of 35,991 shares, the short-interest ratio is presently 0.6 days. Currently, 0.2% of the company’s shares are sold short.

Columbia Research Enhanced Value ETF Trading Up 1.1%

NYSEARCA:REVS traded up $0.34 during midday trading on Wednesday, hitting $31.78. 13,633 shares of the company traded hands, compared to its average volume of 54,256. Columbia Research Enhanced Value ETF has a 12-month low of $26.28 and a 12-month high of $32.21. The firm has a market capitalization of $292.38 million, a P/E ratio of 16.41 and a beta of 0.80. The firm’s fifty day moving average is $31.18 and its 200-day moving average is $29.83.

Institutional Trading of Columbia Research Enhanced Value ETF

A number of large investors have recently made changes to their positions in REVS. Ruggaard & Associates LLC boosted its position in Columbia Research Enhanced Value ETF by 0.6% in the 1st quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock valued at $1,500,000 after buying an additional 322 shares during the period. Western Wealth Management LLC purchased a new position in Columbia Research Enhanced Value ETF in the first quarter valued at about $29,000. Cetera Investment Advisers bought a new position in shares of Columbia Research Enhanced Value ETF during the 1st quarter worth approximately $300,000. First Interstate Bank acquired a new stake in shares of Columbia Research Enhanced Value ETF in the 1st quarter worth $1,321,000. Finally, World Investment Advisors grew its stake in shares of Columbia Research Enhanced Value ETF by 12.8% during the first quarter. World Investment Advisors now owns 46,609 shares of the company’s stock worth $1,334,000 after acquiring an additional 5,283 shares during the last quarter.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.